HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Sale
Common Stock
2025-02-24$9.45/sh−14,168$133,936→ 117,901 total
Footnotes (1)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.